Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Non-Current Assets (2020 - 2025)

BioAtla's Other Non-Current Assets history spans 6 years, with the latest figure at $163000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $163000.0; the TTM value through Dec 2025 reached $163000.0, changed N/A, while the annual FY2025 figure was $163000.0, N/A changed from the prior year.
  • Other Non-Current Assets reached $163000.0 in Q4 2025 per BCAB's latest filing, roughly flat from $163000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $163000.0 in Q2 2025 to a low of $154000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $155750.0, with a median of $154000.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: increased 0.65% in 2022, then fell 0.65% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $154000.0 in 2021, then changed by 0.0% to $154000.0 in 2022, then changed by 0.0% to $154000.0 in 2023, then changed by 0.0% to $154000.0 in 2024, then increased by 5.84% to $163000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Other Non-Current Assets are $163000.0 (Q4 2025), $163000.0 (Q3 2025), and $163000.0 (Q2 2025).